Syros Reports Third Quarter 2018 Financial Results and Highlights Key Accomplishments and Upcoming Milestones

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. SPCX
2. FDX
3. META
4. ABBV
5. SPY
6. BLZE
7. IBM
8. NKE
9. MU
10. ACN

Go back to Syros Reports Third Quarter 2018 Financial Results and Highlights Key Accomplishments and Upcoming Milestones

Syros Pharmaceuticals (SYRS) Misses Q3 EPS by 1c

November 1, 2018 7:24 AM EDT

Syros Pharmaceuticals (NASDAQ: SYRS) reported Q3 EPS of ($0.47), $0.01 worse than the analyst estimate of ($0.46). Revenue for the quarter came in at $400 thousand versus the consensus estimate of $450 thousand.

For earnings history and earnings-related data on Syros Pharmaceuticals (SYRS) click here.

... More